CCL8 and neoplasm: In univariate analysis high expression of SIGLEC1/CCL8 was significantly associated with shorter DSS (Figure 6B; Table S6), along with Her2 status (HR = 2.1, p = 2.3 ×1010), grade (HR = 1.8, p = 1.9 × 10−9) and tumor size (HR = 1.8, p = 0.002).